September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...
September 8, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
September 8, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company dedicated to developing ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 8, 2023 — Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically ...
September 7, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval ...
September 7, 2023 —Jessica Faulkner, PhD, a physiologist whose research is focused on sex differences in cardiovascular ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 7, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced that ...
September 7, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...
September 6, 2023 — The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 6, 2023 — The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser ...
September 6, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...
September 6, 2023 — Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 6, 2023 — GE HealthCare and Mass General Brigham have announced, as part of its initial collaboration, the co ...
September 5, 2023 — New long-term follow-up results from two Phase 3 studies evaluating CAMZYOS (mavacamten), a first-in ...
September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...